Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Nature Clinical Practice. Cardiovascular Medicine
|
November 3, 2005
Does reducing a patient's CRP levels with statin therapy reduce their risk of recurrent cardiovascular events?
Cornelis Kluft
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
|
March 20, 2002
How to search for the role of gene-environment interactions for lipids in humans
Cornelis Kluft
British Journal of Clinical Pharmacology
|
February 24, 2011
Introduction to haemostasis from a pharmacodynamic perspective
Cornelis Kluft, Jacobus Burggraaf
Seminars in Thrombosis and Hemostasis
|
October 28, 2010
External quality assessment for thrombin generation tests: an exploration
Cornelis Kluft, Piet Meijer
EJIFCC
|
January 17, 2019
Standardization of Measurement of Components of the Fibrinolytic System - Introduction and Current Status
Jørgen Gram, Cornelis Kluft, Jørgen Jespersen
Thrombosis and Haemostasis
|
November 3, 2006
Performance goals for the laboratory testing of antithrombin, protein C and protein S
Piet Meijer, Frits Haverkate, Cornelis Kluft
Vascular Pharmacology
|
March 6, 2003
The association between inflammation markers, coronary artery disease and smoking
Moniek P M de Maat, Cornelis Kluft
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 18, 2003
Genetics of C-reactive protein: new possibilities and complications
Cornelis Kluft, Moniek P M de Maat
Seminars in Thrombosis and Hemostasis
|
June 9, 2016
Assessing Safety of Thrombolytic Therapy
Cornelis Kluft, Johannes J Sidelmann, Jørgen B Gram
Vascular Pharmacology
|
March 6, 2003
Relationship between CRP and clinical course of unstable angina depends on assay method
Moniek P M de Maat, Frits Haverkate, Cornelis Kluft
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Nature Clinical Practice. Cardiovascular Medicine
|
November 3, 2005
Does reducing a patient's CRP levels with statin therapy reduce their risk of recurrent cardiovascular events?
Cornelis Kluft
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
|
March 20, 2002
How to search for the role of gene-environment interactions for lipids in humans
Cornelis Kluft
British Journal of Clinical Pharmacology
|
February 24, 2011
Introduction to haemostasis from a pharmacodynamic perspective
Cornelis Kluft, Jacobus Burggraaf
Seminars in Thrombosis and Hemostasis
|
October 28, 2010
External quality assessment for thrombin generation tests: an exploration
Cornelis Kluft, Piet Meijer
EJIFCC
|
January 17, 2019
Standardization of Measurement of Components of the Fibrinolytic System - Introduction and Current Status
Jørgen Gram, Cornelis Kluft, Jørgen Jespersen
Thrombosis and Haemostasis
|
November 3, 2006
Performance goals for the laboratory testing of antithrombin, protein C and protein S
Piet Meijer, Frits Haverkate, Cornelis Kluft
Vascular Pharmacology
|
March 6, 2003
The association between inflammation markers, coronary artery disease and smoking
Moniek P M de Maat, Cornelis Kluft
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 18, 2003
Genetics of C-reactive protein: new possibilities and complications
Cornelis Kluft, Moniek P M de Maat
Seminars in Thrombosis and Hemostasis
|
June 9, 2016
Assessing Safety of Thrombolytic Therapy
Cornelis Kluft, Johannes J Sidelmann, Jørgen B Gram
Vascular Pharmacology
|
March 6, 2003
Relationship between CRP and clinical course of unstable angina depends on assay method
Moniek P M de Maat, Frits Haverkate, Cornelis Kluft
Page
of 10